XML 31 R23.htm IDEA: XBRL DOCUMENT v3.23.3
SHAREHOLDERS' EQUITY (Tables)
 6 Months Ended
Jun. 30, 2023
Share-based Payment Arrangement, Noncash Expense [Abstract]  
Schedule of stock options granted
 
   
Six months ended
June 30, 2023
  
   
Number
of options
    
Weighted
average
exercise
price
    
Weighted average remaining contractual term
(in years)
    
Aggregate
intrinsic
value
  
                         
Outstanding at beginning of year
    
5,305,732
    
$
2.95
      
3.83
    
$
19
  
Granted
    
607,478
      
1.93
                  
Exercised
    
(17,915
)
    
1.70
                  
Forfeited or expired
    
(644,249
)
    
3.06
                  
                                 
Outstanding at end of the period
    
5,251,046
      
2.82
      
3.58
    
$
153
  
                                 
Options exercisable at end of the period
    
2,725,843
    
$
2.94
      
2.52
    
$
17
  
                                 
Vested and expected to vest
    
3,933,732
    
$
2.87
      
3.19
    
$
76
  
Schedule of RSUs granted
 
   
Number of RSUs
    
Weighted average fair value
  
             
Unvested at beginning of year
    
2,108,339
        
Granted
    
429,620
    
$
1.88
  
Vested
    
(20,656
)
        
Forfeited
    
(159,303
)
        
                 
Unvested at end of period
  
$
2,358,000
          
Schedule of equity-based compensation expense
 
   
Six months ended
June 30,
  
   
2022
    
2023
  
   
Unaudited
  
             
Cost of revenues
    
257
      
226
  
Research and development
    
20
      
477
  
Sales and Marketing
    
579
      
738
  
General and administrative
    
579
      
536
  
                 
Total share-based compensation expense
  
$
1,435
    
$
1,977